Case-Based Roundtable Meetings Spotlight

Case-Based Roundtable Meetings Spotlight: May 2023

Case-Based Roundtable Meetings Spotlight: April 2, 2023

Case-Based Roundtable Meetings Spotlight: April 1, 2023

Case-Based Roundtable Meetings Spotlight: March 2, 2023
Volume: 6
Issue: 4

Case-Based Roundtable Meetings Spotlight: March 1, 2023
Volume: 6
Issue: 3

Case-Based Roundtable Meetings Spotlight: February 2023
Volume: 6
Issue: 2

Case-Based Roundtable Meetings Spotlight: January 2023

Case-Based Roundtable Meetings Spotlight: December 2, 2022

Case-Based Roundtable Meetings Spotlight: December 1, 2022

Case-Based Roundtable Meetings Spotlight: November 1, 2022

Case-Based Roundtable Meetings Spotlight: November 2, 2022

October 2, 2022

October 1 2022

Case-Based Roundtable Meetings Spotlight: September 2022

Case-Based Roundtable Meetings Spotlight: August 2022
Volume: 5
Issue: 11

Case-Based Roundtable Meetings Spotlight: July 2, 2022

Case-Based Roundtable Meetings Spotlight: July 1, 2022

Case-Based Roundtable Meetings Spotlight: June 2022

Case-Based Roundtable Meetings Spotlight: May 2022

Case-Based Roundtable Meetings Spotlight: April 2 2022

Case-Based Roundtable Meetings Spotlight: April 1 2022

Case-Based Roundtable Meetings Spotlight: March 2022

Case-Based Roundtable Meetings Spotlight: February 1, 2022

Case-Based Roundtable Meetings Spotlight: February 2, 2022

Case-Based Roundtable Meetings Spotlight: January 1, 2022

Case-Based Roundtable Meetings Spotlight: December 2, 2021

Case-Based Roundtable Meetings Spotlight December 1, 2021

Case-Based Roundtable Meeting Spotlight November 1 2021

Case-Based Roundtable Meeting Spotlight November 2, 2021

Case-Based Roundtable Meeting Spotlight October 1 2021
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Enfortumab Vedotin Plus Pembrolizumab Improves Survival in MIBC
2
Teclistamab/Daratumumab Earns FDA Priority Voucher for R/R Myeloma
3
Early Relapse Guides Use of CAR T vs Other Options in LBCL
4
FDA Fast-Tracks Muzastotug Combo in MSS Metastatic Colorectal Cancer
5

